Clinical Trial

ONO-4538 Study in Patients With Richter's Transformation

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Protocol Amendment History 1 change
notable Sponsor changed: Ono Pharmaceutical Co. Ltd -> Ono Pharmaceutical Co., Ltd. 2026-04-19
Trial Details
NCT Number NCT06936943
Lead Sponsor Ono Pharmaceutical Co. Ltd
Conditions Richter's Transformation
Enrollment 14 participants
Start Date 2025-11-19
Primary Completion 2029-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13